Citations (270)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Jaya Chakravarty & Shyam Sundar. (2019) Current and emerging medications for the treatment of leishmaniasis. Expert Opinion on Pharmacotherapy 20:10, pages 1251-1265.
Read now
Read now
Shyam Sundar, Jaya Chakravarty & Lalit P Meena. (2019) Leishmaniasis: treatment, drug resistance and emerging therapies. Expert Opinion on Orphan Drugs 7:1, pages 1-10.
Read now
Read now
A.J. Trájer, T. Hammer & J. Padisák. (2018) Reflection of the Neogene–Quaternary phylogeography in the recent distribution limiting climatic factors of eight Mediterranean Phlebotomus species (Diptera: Psychodidae). Journal of Natural History 52:27-28, pages 1763-1784.
Read now
Read now
Vanessa Ortega, Selma Giorgio & Eneida de Paula. (2017) Liposomal formulations in the pharmacological treatment of leishmaniasis: a review. Journal of Liposome Research 27:3, pages 234-248.
Read now
Read now
Mekuriaw Alemayehu, Mamo Wubshet & Nebiyu Mesfin. (2016) Magnitude of visceral leishmaniasis and poor treatment outcome among HIV patients: meta-analysis and systematic review. HIV/AIDS - Research and Palliative Care 8, pages 75-81.
Read now
Read now
Paul Torpiano & David Pace. (2015) Leishmaniasis: diagnostic issues in Europe. Expert Review of Anti-infective Therapy 13:9, pages 1123-1138.
Read now
Read now
Shyam Sundar & Jaya Chakravarty. (2015) An update on pharmacotherapy for leishmaniasis. Expert Opinion on Pharmacotherapy 16:2, pages 237-252.
Read now
Read now
Shyam Sundar & Jaya Chakravarty. (2015) Investigational drugs for visceral leishmaniasis. Expert Opinion on Investigational Drugs 24:1, pages 43-59.
Read now
Read now
D Standaert, F Laurent, S Jonckheere, JM Scheiff, B Vandercam & JC Yombi. (2013) RELAPSING VISCERAL LEISHMANIASIS IN A HIV-1 INFECTED PATIENT WITH ADVANCED DISEASE. Acta Clinica Belgica 68:2, pages 124-127.
Read now
Read now
Shyam Sundar & Jaya Chakravarty. (2013) Leishmaniasis: an update of current pharmacotherapy. Expert Opinion on Pharmacotherapy 14:1, pages 53-63.
Read now
Read now
Delaram Doroud & Sima Rafati. (2012) Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems. Expert Review of Vaccines 11:1, pages 69-86.
Read now
Read now
Pascal Launois, Fabienne Tacchini-Cottier & Marie-Paul Kieny. (2008) Cutaneous leishmaniasis: progress towards a vaccine. Expert Review of Vaccines 7:8, pages 1277-1287.
Read now
Read now
Nuno Marques, Rosa Sá, Filomena Coelho, Joaquim Oliveira, J. Saraiva Da Cunha & A. Meliço-Silvestre. (2008) Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients. Scandinavian Journal of Infectious Diseases 40:6-7, pages 523-526.
Read now
Read now
Margriet den Boer & Robert N Davidson. (2006) Treatment options for visceral leishmaniasis. Expert Review of Anti-infective Therapy 4:2, pages 187-197.
Read now
Read now
K. Azizi, Y. Rassi, E. Javadian, M. H. Motazedian, S. Rafizadeh, M. R. Yaghoobi Ershadi & M. Mohebali. (2006)
Phlebotomus (Paraphlebotomus) alexandri: a probable vector of Leishmania infantum in Iran. Annals of Tropical Medicine & Parasitology 100:1, pages 63-68.
Read now
Read now
M. Olivier, R. Badaró, F. J. Medrano & J. Moreno. (2003) The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms. Annals of Tropical Medicine & Parasitology 97:sup1, pages 79-98.
Read now
Read now
R. Molina, L. Gradoni & J. Alvar. (2003) HIV and the transmission of Leishmania
. Annals of Tropical Medicine & Parasitology 97:sup1, pages 29-45.
Read now
Read now
A. Rabello, M. Orsini & J. Disch. (2003)
Leishmania/HIV co-infection in Brazil: an appraisal. Annals of Tropical Medicine & Parasitology 97:sup1, pages 17-28.
Read now
Read now
Articles from other publishers (252)
Marleen Boelaert, Fabiana Alves & Shyam Sundar. 2024. Manson's Tropical Diseases. Manson's Tropical Diseases
646
668
.
Paul M. Kaye, Greg Matlashewski, Sakshi Mohan, Epke Le Rutte, Dinesh Mondal, Ali Khamesipour & Stefano Malvolti. (2023) Vaccine value profile for leishmaniasis. Vaccine 41, pages S153-S175.
Crossref
Crossref
Rezika Mohammed, Roma Melkamu, Myrthe Pareyn, Said Abdellati, Tadfe Bogale, Asinakew Engidaw, Abiy Kinfu, Tibebu Girma & Johan van Griensven. (2023) Detection of asymptomatic Leishmania infection in blood donors at two blood banks in Ethiopia. PLOS Neglected Tropical Diseases 17:3, pages e0011142.
Crossref
Crossref
Mehmet ÇABALAK, Gülnaz ÇULHA, Tuğba KAYA, Yusuf ÖNLEN, Burcu KÜÇÜKESER & Hasibullah YAQOOBİ. (2022) Investigation of visceral leishmaniasis and coinfection of intestinal parasites in HIV-positive patientsHIV pozitif hastalarda visseral leishmaniasis ve intestinal parazitlerin koenfeksiyonunun araştırılması. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi.
Crossref
Crossref
Luis G. C. ReinaldoRaimundo J. C. Araújo-JúniorThiago M. DinizRafael D. MouraAntônio J. Meneses-FilhoCaio V. V. M. FurtadoWashington L. C. SantosDorcas L. CostaKelsen D. EulálioGabriel R. Ferreira & Carlos H. N. Costa. (2022) Splenectomy in Patients with Visceral Leishmaniasis Resistant to Conventional Therapy and Secondary Prophylaxis: A Retrospective Cohort. The American Journal of Tropical Medicine and Hygiene 107:2, pages 342-348.
Crossref
Crossref
Ikram Ait Maatallah, Khadija Akarid & Meryem Lemrani. (2022) Tissue tropism: Is it an intrinsic characteristic of Leishmania species?. Acta Tropica 232, pages 106512.
Crossref
Crossref
Jeet Banerjee, Anindita Bhattacharjee, Arunima Biswas & Shital K. Chattopadhyay. (2022) Synthesis, bio-physical and anti-leishmanial studies of some novel indolo[3,2-a]phenanthridine derivatives. Bioorganic Chemistry 123, pages 105766.
Crossref
Crossref
Anna Fernández‐Arévalo, Cristina Ballart, Jordana Muñoz‐Basagoiti, Leire Basarte, Gonzalo Lobato, Albert Arnau, Alba Abras, Silvia Tebar, Teresa Llovet, Patrick Lami, Francine Pratlong, Mercè Alsina, Esther Roe, Lluís Puig, Carme Muñoz & Montserrat Gállego. (2021) Autochthonous and imported tegumentary leishmaniasis in Catalonia (Spain): Aetiological evolution in the last four decades and usefulness of different typing approaches based on biochemical, molecular and proteomic markers. Transboundary and Emerging Diseases 69:3, pages 1404-1418.
Crossref
Crossref
Manoj Kumar Singh, Arpita Das, Rudra P Saha, Joydeep Paul & Debkumar Nandi. (2022) Leishmaniasis: Plants as a source of antileishmanial agents. Journal of Experimental Biology and Agricultural Sciences 10:1, pages 227-247.
Crossref
Crossref
Nataša Miladinović-TasićL.L., Katarina NikolićZ.Z. & Kristina ArizanovićG.G.. (2022) Oral cavity protozoa relevant in the practice of dentistry. Acta stomatologica Naissi 38:85, pages 2352-2369.
Crossref
Crossref
Ma. Florencia Peralta, Nadina A. Usseglio, Ma. Estefanía Bracamonte, Ma. Laura Guzmán, Ma. Eugenia Olivera, J. Diego Marco, Paola A. Barroso & Dolores C. Carrer. (2021) Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis. Drug Delivery and Translational Research 12:1, pages 180-196.
Crossref
Crossref
Ehab Kotb Elmahallawy, Stefania Zanet, Marco Poggi, Khalaf F. Alsharif, Maha S. Lokman, Anna Trisciuoglio & Ezio Ferroglio. (2021) Prognostic Value of Immunoglobulin G (IgG) Patterns by Western Blotting Immunodetection in Treated Dogs Previously Infected with Leishmania infantum. Veterinary Sciences 8:12, pages 293.
Crossref
Crossref
Hermali Silva, Achala Liyanage, Theja Deerasinghe, Vasana Chandrasekara, Kalaivani Chellappan & Nadira D. Karunaweera. (2021) Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination. PLOS ONE 16:10, pages e0259009.
Crossref
Crossref
I. Abadías-Granado, A. Diago, P.A. Cerro, A.M. Palma-Ruiz & Y. Gilaberte. (2021) Cutaneous and Mucocutaneous Leishmaniasis. Actas Dermo-Sifiliográficas (English Edition) 112:7, pages 601-618.
Crossref
Crossref
I. Abadías-Granado, A. Diago, P.A. Cerro, A.M. Palma-Ruiz & Y. Gilaberte. (2021) Leishmaniasis cutánea y mucocutánea. Actas Dermo-Sifiliográficas 112:7, pages 601-618.
Crossref
Crossref
Amit Roy, Sachidananda Behera, Priyanka H. Mazire, Bhavini Kumari, Abhishek Mandal, Bidyut Purkait, Payel Ghosh, Prolay Das & Pradeep Das. (2021) The HIV − 1 protease inhibitor Amprenavir targets Leishmania donovani topoisomerase I and induces oxidative stress-mediated programmed cell death. Parasitology International 82, pages 102287.
Crossref
Crossref
Myrsini Tzani, Alicia Barrasa, Annita Vakali, Theano Georgakopoulou, Kassiani Mellou & Danai Pervanidou. (2021) Surveillance data for human leishmaniasis indicate the need for a sustainable action plan for its management and control, Greece, 2004 to 2018. Eurosurveillance 26:18.
Crossref
Crossref
Carolina Angélica Libório Machado, Anaiá da Paixão Sevá, Arianna Araujo Falcão Andrade e Silva & Mauricio Claudio Horta. (2021) Epidemiological profile and lethality of visceral leishmaniasis/human immunodeficiency virus co-infection in an endemic area in Northeast Brazil. Revista da Sociedade Brasileira de Medicina Tropical 54.
Crossref
Crossref
Tanja Barth-Jaeggi & Pascal Mäser. 2021. Neglected Tropical Diseases - Europe and Central Asia. Neglected Tropical Diseases - Europe and Central Asia
83
99
.
Dirlei Nico, Luciana Conde & Clarisa Beatriz Palatnik de Sousa. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery
1
21
.
Mehdi Mohebali & Yonas Yimam. (2020) Prevalence estimates of human immunodeficiency virus (HIV) infection among visceral leishmaniasis infected people in Northwest Ethiopia: a systematic review and meta-analysis. BMC Infectious Diseases 20:1.
Crossref
Crossref
Juliana Quero Reimão, Elizabeth Magiolo Coser, Monica Ran Lee & Adriano Cappellazzo Coelho. (2020) Laboratory Diagnosis of Cutaneous and Visceral Leishmaniasis: Current and Future Methods. Microorganisms 8:11, pages 1632.
Crossref
Crossref
Richard G. Wamai, Jorja Kahn, Jamie McGloin & Galen Ziaggi. (2020) Visceral leishmaniasis: a global overview. Journal of Global Health Science 2:1.
Crossref
Crossref
Somenath Roy Chowdhury, Vivek Kumar Gupta & Hemanta K. Majumder. 2020. Bioactive Natural Products. Bioactive Natural Products
389
410
.
Rosa M. Reguera, Ehab K. Elmahallawy, Carlos García-Estrada, Rubén Carbajo-Andrés & Rafael Balaña-Fouce. (2019) DNA Topoisomerases of Leishmania Parasites; Druggable Targets for Drug Discovery. Current Medicinal Chemistry 26:32, pages 5900-5923.
Crossref
Crossref
M. Daoudi, S. Boussaa, M. Echchakery & A. Boumezzough. (2019) Risk mapping of human HIV-Leishmaniasis co-infection in Morocco. Heliyon 5:9, pages e02419.
Crossref
Crossref
Santiago N. Chanquia, Facundo Larregui, Vanesa Puente, Carlos Labriola, Elisa Lombardo & Guadalupe García Liñares. (2019) Synthesis and biological evaluation of new quinoline derivatives as antileishmanial and antitrypanosomal agents. Bioorganic Chemistry 83, pages 526-534.
Crossref
Crossref
Mazin A. S. Abdelwahid, Tilal Elsaman, Malik S. Mohamed, Sara A. Latif, Moawia M. Mukhtar & Magdi A. Mohamed. (2019) Synthesis, Characterization, and Antileishmanial Activity of Certain Quinoline-4-carboxylic Acids. Journal of Chemistry 2019, pages 1-9.
Crossref
Crossref
Imène Ben Abda, Rym Ben-Abdallah, Houda Hammami, Meriem Ben Abid, Hela Mdimagh-Kchir, Karim Bahri, Emna Siala, Karim Aoun & Aida Bouratbine. (2019) Unexpected diagnosis of basal cell carcinoma in a patient presenting with a secondary location of Leishmania parasites in the skin. Pan African Medical Journal 34.
Crossref
Crossref
Wim Adriaensen, Saïd Abdellati, Saskia van Henten, Yonas Gedamu, Ermias Diro, Florian Vogt, Bewketu Mengesha, Emebet Adem, Luc Kestens & Johan van Griensven. (2018) Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients. Frontiers in Cellular and Infection Microbiology 8.
Crossref
Crossref
Diego Lins GuedesZulma MedeirosElis Dionísio da SilvaAudrey Violeta Martins de VasconcelosMariana Santana da SilvaMaria Almerice Lopes da SilvaPaulo Sérgio Ramos de AraújoDemócrito de Barros Miranda-Filho. (2018) Visceral Leishmaniasis in Hospitalized HIV-Infected Patients in Pernambuco, Brazil. The American Journal of Tropical Medicine and Hygiene 99:6, pages 1541-1546.
Crossref
Crossref
P. Tatarelli, G. Fornaro, V. Del Bono, L.A. Nicolini, A.M. Raiola, F. Gualandi, R. Varaldo, T. Di Muccio, M. Gramiccia, L. Gradoni, E. Angelucci, C. Viscoli & M. Mikulska. (2018) Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature. Journal of Infection and Chemotherapy 24:12, pages 990-994.
Crossref
Crossref
Mona M Okba, Omar M Sabry, An Matheeussen & Essam Abdel-Sattar. (2018)
In vitro
antiprotozoal activity of some medicinal plants against sleeping sickness, Chagas disease and leishmaniasis
. Future Medicinal Chemistry 10:22, pages 2607-2617.
Crossref
Crossref
Ana Alonso, Vicente Larraga & Pedro J. Alcolea. (2018) The contribution of DNA microarray technology to gene expression profiling in Leishmania spp.: A retrospective view. Acta Tropica 187, pages 129-139.
Crossref
Crossref
Shabnam Asfaram, Saeed Hosseini Teshnizi, Mahdi Fakhar, Elham Sadat Banimostafavi & Masoud Soosaraei. (2018) Is urine a reliable clinical sample for the diagnosis of human visceral leishmaniasis? A systematic review and meta-analysis. Parasitology International 67:5, pages 575-583.
Crossref
Crossref
S. K. Söbirk, M. Inghammar, M. Collin & L. Davidsson. (2018) Imported leishmaniasis in Sweden 1993–2016. Epidemiology and Infection 146:10, pages 1267-1274.
Crossref
Crossref
SHYAM SUNDAR & ANUP SINGH. (2017) Chemotherapeutics of visceral leishmaniasis: present and future developments. Parasitology 145:4, pages 481-489.
Crossref
Crossref
M. Echchakery, J. Nieto, S. Boussaa, N. El Fajali, S. Ortega, K. Souhail, H. Aajly, C. Chicharro, E. Carrillo, J. Moreno & A. Boumezzough. (2018) Asymptomatic carriers of Leishmania infantum in patients infected with human immunodeficiency virus (HIV) in Morocco. Parasitology Research 117:4, pages 1237-1244.
Crossref
Crossref
Johan van Griensven, Bewketu Mengesha, Tigist Mekonnen, Helina Fikre, Yegnasew Takele, Emebet Adem, Rezika Mohammed, Koert Ritmeijer, Florian Vogt, Wim Adriaensen & Ermias Diro. (2018) Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia. Frontiers in Cellular and Infection Microbiology 8.
Crossref
Crossref
Shyam Sundar & Jaya Chakravarty. 2018. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
159
176
.
Larry N. Tangie, A. Desmond, Leopold N. Aminde, Annabel M. Ako & P. M. Halle. (2017) Cutaneous leishmaniasis in a severely immunocompromised HIV patient in Kumbo, Northwest region of Cameroon: case report. BMC Research Notes 10:1.
Crossref
Crossref
Mekuriaw Alemayehu, Mamo Wubshet, Nebiyu Mesfin, Aschalew Tamiru & Abebaw Gebayehu. (2017) Health-related quality of life of HIV infected adults with and without Visceral Leishmaniasis in Northwest Ethiopia. Health and Quality of Life Outcomes 15:1.
Crossref
Crossref
Mekuriaw Alemayehu, Mamo Wubshet, Nebiyu Mesfin & Abebaw Gebayehu. (2017) Perceived quality of life among Visceral Leishmaniasis and HIV coinfected migrant male-workers in Northwest Ethiopia: a qualitative study. BMC Public Health 17:1.
Crossref
Crossref
Mekuriaw Alemayehu, Mamo Wubshet, Nebiyu Mesfin & Abebaw Gebayehu. (2017) Prevalence of Human Immunodeficiency Virus and associated factors among Visceral Leishmaniasis infected patients in Northwest Ethiopia: a facility based cross-sectional study. BMC Infectious Diseases 17:1.
Crossref
Crossref
Reza Keikha, Mojgan Bandehpour, Shabnam Jeibouei & Bahram Kazemi. (2017) Immunogenicity and Efficacy of Polytope DNA Vaccine Against Cutaneous Leishmaniosis In Vivo. Health Scope 7:1.
Crossref
Crossref
Supriya Khanra, Nibedeeta R. Sarraf, Anjan K. Das, Syamal Roy & Madhumita Manna. (2017) Miltefosine Resistant Field Isolate From Indian Kala-Azar Patient Shows Similar Phenotype in Experimental Infection. Scientific Reports 7:1.
Crossref
Crossref
Somenath Roy Chowdhury, Ashish Kumar, Joseane Lima Prado Godinho, Sara Teixeira De Macedo Silva, Aline Araujo Zuma, Sourav Saha, Neha Kumari, Juliany Cola Fernandes Rodrigues, Shyam Sundar, Jean-Claude Dujardin, Syamal Roy, Wanderley De Souza, Sibabrata Mukhopadhyay & Hemanta K. Majumder. (2017) Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB. Biochemical Pharmacology 138, pages 19-30.
Crossref
Crossref
Supriya Khanra, Nibedeeta Rani Sarraf, Sangita Lahiry, Syamal Roy & Madhumita Manna. (2017) Leishmania genomics: a brief account. The Nucleus 60:2, pages 227-235.
Crossref
Crossref
Paula Ferreira Brasil, Júlia Araújo de Freitas, Anna Léa Silva Barreto, Camila Marques Adade, Leandro Figueira Reis de Sá, Pamella Constantino-Teles, Fabiano Travanca Toledo, Bruno A. de Sousa, Augusto Cesar Gonçalves, Maria Teresa Villela Romanos, João V. Comasseto, Alcindo A. dos Santos, Ana Claudia Tessis, Thais Souto-Padrón, Rosangela Maria A. Soares & Antonio Ferreira-Pereira. (2017) Antiproliferative and ultrastructural effects of phenethylamine derivatives on promastigotes and amastigotes of Leishmania ( Leishmania ) infantum chagasi. Parasitology International 66:2, pages 47-55.
Crossref
Crossref
Hossein Rezvan, Ali reza Nourian & Sahar Hamoon Navard. (2017) An Overview on Leishmania Diagnosis. Journal of Medical Microbiology and Infectious Diseases 5:1, pages 1-11.
Crossref
Crossref
F. Vitola, R. Fendrich, C.R. Soccol, D. Guedes, A. Pandey & V. Thomaz-Soccol. 2017. Current Developments in Biotechnology and Bioengineering. Current Developments in Biotechnology and Bioengineering
563
594
.
Shyam Sundar & Jaya Chakravarty. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
1293
1304
.
Carlos Brisola Marcondes, Domenico Otranto & Filipe Dantas-Torres. 2017. Arthropod Borne Diseases. Arthropod Borne Diseases
223
244
.
Rômulo Pessoa-e-Silva, Lays Adrianne Mendonça Trajano-Silva, Maria Almerice Lopes da Silva, Suênia da Cunha Gonçalves-de-Albuquerque, Tayná Correia de Goes, Rayana Carla Silva de Morais, Fábio Lopes de Melo & Milena de Paiva-Cavalcanti. (2016) Evaluation of urine for Leishmania infantum DNA detection by real-time quantitative PCR. Journal of Microbiological Methods 131, pages 34-41.
Crossref
Crossref
Alicia Castro, Eugenia Carrillo, Juan V. San Martín, Laura Botana, Laura Molina, Belén Matía, Laura Fernandez, Luis Horrillo, Ana Ibarra-Meneses, Carmen Sanchez, Jose M. Ruiz-Giardin & Javier Moreno. (2016) Lymphoproliferative response after stimulation with soluble leishmania antigen (SLA) as a predictor of visceral leishmaniasis (VL) relapse in HIV+ patients. Acta Tropica 164, pages 345-351.
Crossref
Crossref
Supriya Khanra, Nibedeeta Rani Sarraf, Shantanabha Das, Anjan Kumar Das, Syamal Roy & Madhumita Manna. (2016) Genetic markers for antimony resistant clinical isolates differentiation from Indian Kala-azar. Acta Tropica 164, pages 177-184.
Crossref
Crossref
Mohammad Asif. (2016) Biologically active compounds from natural and marine natural organisms with antituberculosis, antimalarial, leishmaniasis, trypanosomiasis, anthelmintic, antibacterial, antifungal, antiprotozoal, and antiviral activities. TANG [HUMANITAS MEDICINE] 6:4, pages 22.1-22.19.
Crossref
Crossref
A. Oryan & M. Akbari. (2016) Worldwide risk factors in leishmaniasis. Asian Pacific Journal of Tropical Medicine 9:10, pages 925-932.
Crossref
Crossref
Shyam Sundar & Anup Singh. (2016) Recent developments and future prospects in the treatment of visceral leishmaniasis. Therapeutic Advances in Infectious Disease 3:3-4, pages 98-109.
Crossref
Crossref
Eduard E Zijlstra. (2016) Visceral leishmaniasis: a forgotten epidemic. Archives of Disease in Childhood 101:6, pages 561-567.
Crossref
Crossref
Alhelí Rodríguez-Cortés, Eugenia Carrillo, Susanna Martorell, Felicitat Todolí, Ana Ojeda, Alba Martínez-Flórez, Alicia Urniza, Javier Moreno & Jordi Alberola. (2016) Compartmentalized Immune Response in Leishmaniasis: Changing Patterns throughout the Disease. PLOS ONE 11:5, pages e0155224.
Crossref
Crossref
Erjona Abazaj. (2016) Prevalence of Visceral Leishmaniasis in Hospitalized Patients as an increasing Public Health Problem. Journal of Microbiology & Experimentation 3:3.
Crossref
Crossref
Ashish Kumar, Somenath Roy Chowdhury, Tapas Sarkar, Tulika Chakrabarti, Hemanta K. Majumder, Tarun Jha & Sibabrata Mukhopadhyay. (2016) A new bisbenzylisoquinoline alkaloid isolated from Thalictrum foliolosum, as a potent inhibitor of DNA topoisomerase IB of Leishmania donovani. Fitoterapia 109, pages 25-30.
Crossref
Crossref
Mehrdad Ghasemian, Mohammad Javad Gharavi, Lame Akhlaghi, Mehdi Mohebali, Ahmad Reza Meamar, Ehsan Aryan, Hormozd Oormazdi & Zahra Ghayour. (2014) SYBR green-based detection of Leishmania infantum DNA using peripheral blood samples. Journal of Parasitic Diseases 40:1, pages 81-87.
Crossref
Crossref
Lynne Shore Garcia. 2016. Diagnostic Medical Parasitology. Diagnostic Medical Parasitology
883
934
.
Eugenia Bifeld & Joachim Clos. (2015) The genetics of Leishmania virulence. Medical Microbiology and Immunology 204:6, pages 619-634.
Crossref
Crossref
Juliana P.S. Mol, Semíramis A. Soave, Andréia P. Turchetti, Guilherme R.G. Pinheiro, Angela T. Pessanha, Marcelo C.C. Malta, Herlandes P. Tinoco, Luiza A. Figueiredo, Nelder F. Gontijo, Tatiane A. Paixão, Ricardo T. Fujiwara & Renato L. Santos. (2015) Transmissibility of Leishmania infantum from maned wolves ( Chrysocyon brachyurus ) and bush dogs ( Speothos venaticus ) to Lutzomyia longipalpis. Veterinary Parasitology 212:3-4, pages 86-91.
Crossref
Crossref
Mehdi Shahbazi, Farnaz Zahedifard, Noushin Saljoughian, Delaram Doroud, Shahram Jamshidi, Niousha Mahdavi, Sadegh Shirian, Yahya Daneshbod, Sayyed Hamid Zarkesh-Esfahani, Barbara Papadopoulou & Sima Rafati. (2015) Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis. Veterinary Parasitology 212:3-4, pages 130-139.
Crossref
Crossref
. (2015) Scientific Opinion on canine leishmaniosis. EFSA Journal 13:4.
Crossref
Crossref
JL Casado, M Abad-Fernández, S Moreno, MJ Pérez-Elías, A Moreno, JI Bernardino & A Vallejo. (2015) Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients. HIV Medicine 16:4, pages 240-248.
Crossref
Crossref
Zaida Herrador, Alin Gherasim, B. Carolina Jimenez, Marisol Granados, Juan Victor San Martín & Pilar Aparicio. (2015) Epidemiological Changes in Leishmaniasis in Spain According to Hospitalization-Based Records, 1997–2011: Raising Awareness towards Leishmaniasis in Non-HIV Patients. PLOS Neglected Tropical Diseases 9:3, pages e0003594.
Crossref
Crossref
J.-P. Gangneux, S. Belaz & F. Robert-Gangneux. (2015) Mise au point et actualités sur la leishmaniose viscérale méditerranéenne. Journal des Anti-infectieux 17:1, pages 25-28.
Crossref
Crossref
A. Vallejo, M. Abad-Fernández, S. Moreno, A. Moreno, M. J. Pérez-Elías, F. Dronda & J. L. Casado. (2014) High levels of CD4+ CTLA-4+ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis. European Journal of Clinical Microbiology & Infectious Diseases 34:2, pages 267-275.
Crossref
Crossref
Mohammadali Davarpanah, Masumeh Rassaei & Fatemeh Sari aslani. (2015) Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran. Case Reports in Infectious Diseases 2015, pages 1-4.
Crossref
Crossref
Fatemeh Mohammadnejad, Fatemeh Ghaffarifar & Iraj Mobedi. (2015) HIV and parasite co-infection epidemiology. Reviews in Medical Microbiology 26:1, pages 20-25.
Crossref
Crossref
Alan J. Magill. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
3091
3107.e4
.
Simon Couture, Rupesh Agrawal, Kate Woods, Diana Lockwood, Carlos E Pavesio & Peter K F Addison. (2014) A case of panuveitis with hypopyon due to presumed ocular leishmaniasis in a HIV patient. Journal of Ophthalmic Inflammation and Infection 4:1.
Crossref
Crossref
A. Komitopoulou, T. Tzenou, J. Baltadakis, J. Apostolidis, D. Karakasis & N. Harhalakis. (2014) Is leishmaniasis an “unusual suspect” of infection in allogeneic transplantation?. Transplant Infectious Disease 16:6, pages 1012-1018.
Crossref
Crossref
Advait S. Nagle, Shilpi Khare, Arun Babu Kumar, Frantisek Supek, Andriy Buchynskyy, Casey J. N. Mathison, Naveen Kumar Chennamaneni, Nagendar Pendem, Frederick S. Buckner, Michael H. Gelb & Valentina Molteni. (2014) Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis. Chemical Reviews 114:22, pages 11305-11347.
Crossref
Crossref
Eduard E. Zijlstra. (2014) PKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses. PLoS Neglected Tropical Diseases 8:11, pages e3258.
Crossref
Crossref
Pasquale Mansueto, Aurelio Seidita, Giustina Vitale & Antonio Cascio. (2014) Transfusion transmitted leishmaniasis. What to do with blood donors from endemic areas?. Travel Medicine and Infectious Disease 12:6, pages 617-627.
Crossref
Crossref
Pasquale Mansueto, Aurelio Seidita, Giustina Vitale & Antonio Cascio. (2014) Leishmaniasis in travelers: A literature review. Travel Medicine and Infectious Disease 12:6, pages 563-581.
Crossref
Crossref
David Pace. (2014) Leishmaniasis. Journal of Infection 69, pages S10-S18.
Crossref
Crossref
Stephanie D. Kruchten, Kristina M. Bacon & Bruce Y. Lee. (2014) The Impact of Human Immunodeficiency Virus (HIV) Co-Infection on the Economic Burden of Cutaneous Leishmaniasis (CL) in Brazil and Potential Value of New CL Drug Treatments. The American Journal of Tropical Medicine and Hygiene 91:3, pages 520-527.
Crossref
Crossref
Begoña Monge-Maillo, Francesca F. Norman, Israel Cruz, Jorge Alvar & Rogelio López-Vélez. (2014) Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region. PLoS Neglected Tropical Diseases 8:8, pages e3021.
Crossref
Crossref
Rieko Chiba, Yosuke Amagai, Akane Tanaka, Ken Katakura & Hiroshi Matsuda. (2014) Nerve growth factor promotes killing of Leishmania donovani by macrophages through the induction of hydrogen peroxide. Microbes and Infection 16:8, pages 702-706.
Crossref
Crossref
Johan van Griensven, Koert Ritmeijer, Lutgarde Lynen & Ermias Diro. (2014) Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines. PLoS Neglected Tropical Diseases 8:7, pages e2916.
Crossref
Crossref
David M Pigott, Samir Bhatt, Nick Golding, Kirsten A Duda, Katherine E Battle, Oliver J Brady, Jane P Messina, Yves Balard, Patrick Bastien, Francine Pratlong, John S Brownstein, Clark C Freifeld, Sumiko R Mekaru, Peter W Gething, Dylan B George, Monica F Myers, Richard Reithinger & Simon I Hay. (2014) Global distribution maps of the leishmaniases. eLife 3.
Crossref
Crossref
Rajendra K. Baharia, Rati Tandon, Amogh A. Sahasrabuddhe, Shyam Sundar & Anuradha Dube. (2014) Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters. PLoS ONE 9:6, pages e97911.
Crossref
Crossref
Francisco Rogerlândio Martins-Melo, Mauricélia da Silveira Lima, Carlos Henrique Alencar, Alberto Novaes RamosJr.Jr. & Jorg Heukelbach. (2014) Epidemiological patterns of mortality due to visceral leishmaniasis and HIV/AIDS co-infection in Brazil, 2000–2011. Transactions of The Royal Society of Tropical Medicine and Hygiene 108:6, pages 338-347.
Crossref
Crossref
Abiodun Falodun, Vincent Imieje, Osayewenre Erharuyi, Ahomafor Joy, Peter Langer, Melissa Jacob, Shabanna Khan, Mohammed Abaldry & Mark Hamann. (2014) Isolation of antileishmanial, antimalarial and antimicrobial metabolites from Jatropha multifida. Asian Pacific Journal of Tropical Biomedicine 4:5, pages 374-378.
Crossref
Crossref
Madeleine Mattin, David Brodbelt, Claire Wylie, Marta Carbonell Antoñanzas, Laia Solano Gallego, Luis Espejo, Solenne Costard & Francisco Zagmutt. (2014) Data collection to characterise the impact of canine leishmaniosis and modelling of the role of animals in spreading Leishmania infantum within the European Union. EFSA Supporting Publications 11:4.
Crossref
Crossref
Sushmita Das, Avishek Halder, Vidya Nand Rabidas, Abhishek Mandal & Pradeep Das. (2014) Specific Noninvasive Detection of Leishmania donovani in Desquamated Buccal Cell Swab Samples from Human Visceral Leishmaniasis-HIV Coinfected Patients. Journal of Clinical Microbiology 52:4, pages 1238-1241.
Crossref
Crossref
J. van Griensven, E. Carrillo, R. López-Vélez, L. Lynen & J. Moreno. (2014) Leishmaniasis in immunosuppressed individuals. Clinical Microbiology and Infection 20:4, pages 286-299.
Crossref
Crossref
Giorgi Babuadze, Jorge Alvar, Daniel Argaw, Harry P. de Koning, Merab Iosava, Merab Kekelidze, Nikoloz Tsertsvadze, David Tsereteli, Giorgi Chakhunashvili, Tamar Mamatsashvili, Nino Beria, Irine Kalandadze, Mikhail Ejov & Paata Imnadze. (2014) Epidemiology of Visceral Leishmaniasis in Georgia. PLoS Neglected Tropical Diseases 8:3, pages e2725.
Crossref
Crossref
Urs Ehehalt, Mirjam Schunk, Mogens Jensenius, Perry J.J. van Genderen, Effrossyni Gkrania-Klotsas, François Chappuis, Patricia Schlagenhauf, Francesco Castelli, Rogelio Lopez-Velez, Philippe Parola, Gerd D. Burchard & Jakob P. Cramer. (2014) Leishmaniasis acquired by travellers to endemic regions in Europe: A EuroTravNet multi-centre study. Travel Medicine and Infectious Disease 12:2, pages 167-172.
Crossref
Crossref
Johannes Austrup & Panagiotis Karanis. (2014) Frequency of MDR1-related p-gp overexpression in Greek Leishmania isolates. Parasitology Research 113:3, pages 1225-1232.
Crossref
Crossref
Giordano Madeddu, Maria Laura Fiori, Pasquale Ena, Francesco Riu, Carla Lovigu, Giuseppe Nunnari, Paola Bagella, Ivana Maida, Sergio Babudieri & Maria Stella Mura. (2014) Mucocutaneous leishmaniasis as presentation of HIV infection in Sardinia, insular Italy. Parasitology International 63:1, pages 35-36.
Crossref
Crossref
Guilherme Almeida Rosa da Silva, Daniel Sugui, Rafael Fernandes Nunes, Karime de Azevedo, Marcelo de Azevedo, Alexandre Marques, Carlos Martins & Fernando Raphael de Almeida Ferry. (2014) Mucocutaneous Leishmaniasis/HIV Coinfection Presented as a Diffuse Desquamative Rash. Case Reports in Infectious Diseases 2014, pages 1-5.
Crossref
Crossref
Myriam Bouchekoua, Sonia Trabelsi, Taieb Ben Abdallah & Samira Khaled. (2014) Visceral leishmaniasis after kidney transplantation: Report of a new case and a review of the literature. Transplantation Reviews 28:1, pages 32-35.
Crossref
Crossref
Marleen Boelaert & Shyam Sundar. 2014. Manson's Tropical Infectious Diseases. Manson's Tropical Infectious Diseases
631
651.e4
.
Keila Priscilla Sakamoto, Guilherme Dias de Melo & Gisele Fabrino Machado. (2013) T and B lymphocytes in the brains of dogs with concomitant seropositivity to three pathogenic protozoans: Leishmania chagasi, Toxoplasma gondii and Neospora caninum. BMC Research Notes 6:1.
Crossref
Crossref
N. Saljoughian, F. Zahedifard, D. Doroud, F. Doustdari, M. Vasei, B. Papadopoulou & S. Rafati. (2013) Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice. Parasite Immunology 35:12, pages 397-408.
Crossref
Crossref
Giuma Harun Abdalmaula, Pamela Barbadoro, Anna Marigliano, Diego Illuminati, Francesco Di Stanislao, Marcello Mario D’Errico & Emilia Prospero. (2013) Human visceral leishmaniasis: A picture from Italy. Journal of Infection and Public Health 6:6, pages 465-472.
Crossref
Crossref
Sourav Saha, Tulika Mukherjee, Sayan Chowdhury, Amartya Mishra, Somenath Roy Chowdhury, Parasuraman Jaisankar, Sibabrata Mukhopadhyay & Hemanta K. Majumder. (2013) The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo. Biochemical Pharmacology 86:12, pages 1673-1687.
Crossref
Crossref
Maria Antoniou, Pantelis Ntais, George Poupalos, Vasiliki Christodoulou, Dimitra Sifaki-Pistola, Francine Pratlong & Ippokratis Messaritakis. (2013) Leishmaniases in Greece. The American Journal of Tropical Medicine and Hygiene 89:5, pages 906-915.
Crossref
Crossref
Luiz Sergio Guedes-Barbosa, Izaias Pereira da Costa, Vander Fernandes, Licia Maria Henrique da Mota, Ivana de Menezes & Morton Aaron Scheinberg. (2013) Leishmaniasis during anti-tumor necrosis factor therapy: Report of 4 cases and review of the literature (additional 28 cases). Seminars in Arthritis and Rheumatism 43:2, pages 152-157.
Crossref
Crossref
Gustavo F. Paz, Ilka A. Reis, Daniel M. Avelar, Elisa C. da Mata Ferreira & Guilherme L. Werneck. (2013) Ectoparasites and anti-Leishmania antibodies: Association in an observational case–control study of dogs from a Brazilian endemic area. Preventive Veterinary Medicine 112:1-2, pages 156-159.
Crossref
Crossref
Uzma Farooq, Sonal Choudhary, Anna H. Chacon, Elizabeth Lebrun, Michael I. Shiman, Jose Hernandez, Clara Milikowski, Francisco A. Kerdel & Paolo Romanelli. (2013) Post-kala-azar dermal leishmaniasis in HIV-infected patients with AIDS: a report of two cases diagnosed in the USA. International Journal of Dermatology 52:9, pages 1098-1104.
Crossref
Crossref
Donald A. Patrick, Stanislav A. Bakunov, Svetlana M. Bakunova, Susan Kilgore Jones, Tanja Wenzler, Todd Barszcz, Arvind Kumar, David W. Boykin, Karl A. Werbovetz, Reto Brun & Richard R. Tidwell. (2013) Synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives. European Journal of Medicinal Chemistry 67, pages 310-324.
Crossref
Crossref
C Chicharro, I P Llanes-Acevedo, E García, J Nieto, J Moreno & I Cruz. (2013) Molecular typing of Leishmania infantum isolates from a leishmaniasis outbreak in Madrid, Spain, 2009 to 2012. Eurosurveillance 18:30.
Crossref
Crossref
R Harizanov, I Rainova, N Tzvetkova, I Kaftandjiev, I Bikov & O Mikov. (2013) Geographical distribution and epidemiological characteristics of visceral leishmaniasis in Bulgaria, 1988 to 2012. Eurosurveillance 18:29, pages 20531.
Crossref
Crossref
Donald A. Patrick, Mohamed A. Ismail, Reem K. Arafa, Tanja Wenzler, Xiaohua Zhu, Trupti Pandharkar, Susan Kilgore Jones, Karl A. Werbovetz, Reto Brun, David W. Boykin & Richard R. Tidwell. (2013)
Synthesis and Antiprotozoal Activity of Dicationic
m
-Terphenyl and 1,3-Dipyridylbenzene Derivatives
. Journal of Medicinal Chemistry 56:13, pages 5473-5494.
Crossref
Crossref
Flávia Lopes Carvalho, Diana Leite Sousa Aires, Zeyle Fernandes Segunda, Conceição Maria Pedrozo e Silva de Azevedo, Rita da Graça Carvalhal Frazão Corrêa, Dorlene Maria Cardoso de Aquino & Arlene de Jesus Mendes Caldas. (2013) Perfil epidemiológico dos indivíduos HIV positivo e coinfecção HIV-Leishmania em um serviço de referência em São Luís, MA, Brasil. Ciência & Saúde Coletiva 18:5, pages 1305-1312.
Crossref
Crossref
Ifeoma Okwor & Jude Eze Uzonna. (2013) The immunology of Leishmania/HIV co-infection. Immunologic Research 56:1, pages 163-171.
Crossref
Crossref
Noushin Saljoughian, Tahereh Taheri, Farnaz Zahedifard, Yasaman Taslimi, Fatemeh Doustdari, Azam Bolhassani, Delaram Doroud, Hiva Azizi, Kazem Heidari, Mohammad Vasei, Nabiollah Namvar Asl, Barbara Papadopoulou & Sima Rafati. (2013) Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis. PLoS Neglected Tropical Diseases 7:4, pages e2174.
Crossref
Crossref
Iúri Paz Lima, Marina Costa Müller, Thiago Ayres Holanda, Michael Harhay, Carlos Henrique Nery Costa & Dorcas Lamounier Costa. (2013) Human immunodeficiency virus/Leishmania infantum in the first foci of urban American visceral leishmaniasis: clinical presentation from 1994 to 2010. Revista da Sociedade Brasileira de Medicina Tropical 46:2, pages 156-160.
Crossref
Crossref
M. Hide, E. Marion, C. Pomares, R. Fisa, P. Marty & A.L. Bañuls. (2013) Parasitic genotypes appear to differ in leishmaniasis patients compared with asymptomatic related carriers. International Journal for Parasitology 43:5, pages 389-397.
Crossref
Crossref
P. Donati, G. Paolino, C. Panetta, L. Muscardin, C. Cota & M. Giuliani. (2013) Visceral leishmaniasis revealed by a squamous cell carcinoma in an HIV-1 infected patient. Infection 41:2, pages 575-578.
Crossref
Crossref
Laura-Isobel McCall, Wen-Wei Zhang & Greg Matlashewski. (2013) Determinants for the Development of Visceral Leishmaniasis Disease. PLoS Pathogens 9:1, pages e1003053.
Crossref
Crossref
Ali Zandieh, Basira Zandieh & Ladan Dastgheib. (2013) Dissemination of localized cutaneous leishmaniasis in an organ transplant recipient: case report and literature review. International Journal of Dermatology 52:1, pages 59-62.
Crossref
Crossref
Shyam Sundar & Jaya Chakravarty. 2013. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
183
198
.
Jean-Claude Dujardin & Saskia Decuypere. 2013. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
65
83
.
Bhuwan B. Mishra, Navneet Kishore, Rakesh K. Singh & Vinod Kumar Tiwari. 2013. Natural Products. Natural Products
1263
1299
.
Awanish KumarAwanish Kumar. 2013. Leishmania and Leishmaniasis. Leishmania and Leishmaniasis
1
11
.
Shyam Sundar & Jaya Chakravarty. 2013. Challenges in Infectious Diseases. Challenges in Infectious Diseases
247
264
.
Marco André Loureiro Tonini, Elenice Moreira Lemos, Alexandre Barbosa Reis, Wendel Coura Vital, Edelberto Santos Dias & Reynaldo Dietze. (2012) First description of autochthonous canine visceral leishmaniasis in the metropolitan region of Vitória, State of Espírito Santo, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 45:6, pages 754-756.
Crossref
Crossref
Lisa Sattenspiel & Svenn-Erik Mamelund. (2012) COCIRCULATING EPIDEMICS, CHRONIC HEALTH PROBLEMS, AND SOCIAL CONDITIONS IN EARLY 20TH CENTURY LABRADOR AND ALASKA. Annals of Anthropological Practice 36:2, pages 402-421.
Crossref
Crossref
Mahamaya Sharma & Ashwini Malhotra. (2011) Isolated leishmanial lymphadenopathy – A rare type of leishmaniasis in India: A Case Report. Diagnostic Cytopathology 40:11, pages 1002-1004.
Crossref
Crossref
Júlia Cristina Maksoud Brazuna, Elaine Araujo e Silva, Júlio Maksoud Brazuna, Iara Helena Domingos, Neuma Chaves, Michael Robin Honer, Valter Joost van Onselen & Ana Lúcia Lyrio de Oliveira. (2012) Profile and geographic distribution of reported cases of visceral leishmaniasis in Campo Grande, State of Mato Grosso do Sul, Brazil, from 2002 to 2009. Revista da Sociedade Brasileira de Medicina Tropical 45:5, pages 601-606.
Crossref
Crossref
Rosana Regina de Saldanha, Marianna Carminatti Martins-Papa, Raimunda Nonata Ribeiro Sampaio & Maria Imaculada Muniz-Junqueira. (2012) Meglumine antimonate treatment enhances phagocytosis and TNF-α production by monocytes in human cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 106:10, pages 596-603.
Crossref
Crossref
Rui M. Lopes, M. Luísa Corvo, Carla V. Eleutério, Manuela C. Carvalheiro, Effie Scoulica & M. Eugénia M. Cruz. (2012) Formulation of oryzalin (ORZ) liposomes: In vitro studies and in vivo fate. European Journal of Pharmaceutics and Biopharmaceutics 82:2, pages 281-290.
Crossref
Crossref
Javier Moreno. 2012. Immunity to Parasitic Infection. Immunity to Parasitic Infection
353
360
.
Sami Lakhal, Salima Mekki, Imène Ben-Abda, Mohamed Mousli, Fethi Amri, Karim Aoun & Aïda Bouratbine. (2012) Evaluation of an Enzyme-Linked Immunosorbent Assay Based on Crude Leishmania Histone Proteins for Serodiagnosis of Human Infantile Visceral Leishmaniasis. Clinical and Vaccine Immunology 19:9, pages 1487-1491.
Crossref
Crossref
Rajalakshmi Rajasekaran & Yi-Ping Phoebe Chen. (2012) Probing the structure of Leishmania major DHFR TS and structure based virtual screening of peptide library for the identification of anti-leishmanial leads. Journal of Molecular Modeling 18:9, pages 4089-4100.
Crossref
Crossref
Guadalupe García Liñares, Gonzalo Parraud, Carlos Labriola & Alicia Baldessari. (2012) Chemoenzymatic synthesis and biological evaluation of 2- and 3-hydroxypyridine derivatives against Leishmania mexicana. Bioorganic & Medicinal Chemistry 20:15, pages 4614-4624.
Crossref
Crossref
Alan Gunn & Sarah J. Pitt. 2012. Parasitology. Parasitology
375
429
.
Pramod Kumar Kushawaha, Reema Gupta, Chandra Dev Pati Tripathi, Shyam Sundar & Anuradha Dube. (2012) Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis. PLoS ONE 7:4, pages e35670.
Crossref
Crossref
Guenael Freire de Souza, Fernando Biscione, Dirceu Bartolomeu Greco & Ana Rabello. (2012) Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patients. Revista da Sociedade Brasileira de Medicina Tropical 45:2, pages 147-150.
Crossref
Crossref
D Alon & M Chowers. (2012) Successful therapeutic splenectomy in an HIV patient with relapsing visceral leishmaniasis. International Journal of STD & AIDS 23:4, pages 289-290.
Crossref
Crossref
Vasiliki ChristodoulouMaria AntoniouPantelis NtaisIppokratis MessaritakisVladimir IvovicJean-Pierre DedetFrancine PratlongVít DvorakYiannis Tselentis. (2012) Re-Emergence of Visceral and Cutaneous Leishmaniasis in the Greek Island of Crete. Vector-Borne and Zoonotic Diseases 12:3, pages 214-222.
Crossref
Crossref
Omer Bébé Ngouateu, Pierre Kollo, Christophe Ravel, Jacques Dereure, Pierre Kamtchouing, Albert Same-Ekobo, Esther von Stebut, Marcus Maurer & Blaise Dondji. (2012) Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional study. Transactions of the Royal Society of Tropical Medicine and Hygiene 106:3, pages 137-142.
Crossref
Crossref
R. Lopes, C.V. Eleutério, L.M.D. Gonçalves, M.E.M. Cruz & A.J. Almeida. (2012) Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. European Journal of Pharmaceutical Sciences 45:4, pages 442-450.
Crossref
Crossref
Gurumurthy Srividya, Arpita Kulshrestha, Ruchi Singh & Poonam Salotra. (2011) Diagnosis of visceral leishmaniasis: developments over the last decade. Parasitology Research 110:3, pages 1065-1078.
Crossref
Crossref
Rafael Balaña-Fouce, Estefanía Calvo-Álvarez, Raquel Álvarez-Velilla, Christopher F. Prada, Yolanda Pérez-Pertejo & Rosa M. Reguera. (2012) Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis. Molecular and Biochemical Parasitology 181:2, pages 85-93.
Crossref
Crossref
Francisco Assis Lima Costa. (2012) The Dog as a Risk Factor in Transmission of Visceral Leishmaniasis: A Review. Advances in Infectious Diseases 02:02, pages 37-47.
Crossref
Crossref
R. F. Rodrigues, K. S. Charret, M. C. Campos, V. Amaral, A. Echevarria, C. dos Reis, M. M. Canto-Cavalheiro & L. L. Leon. (2011) The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis. Journal of Antimicrobial Chemotherapy 67:1, pages 182-190.
Crossref
Crossref
Sanchita Datta, Rupchand Adak, Priyanka Chakraborty, Arun Kumar Haldar, Surajit Bhattacharjee, Anindita Chakraborty, Syamal Roy & Madhumita Manna. (2012) Radio-attenuated leishmanial parasites as immunoprophylactic agent against experimental murine visceral leishmaniasis. Experimental Parasitology 130:1, pages 39-47.
Crossref
Crossref
Ruth Gil-Prieto, Stefan Walter, Jorge Alvar & Angel Gil de Miguel. (2011) Epidemiology of Leishmaniasis in Spain Based on Hospitalization Records (1997–2008). The American Journal of Tropical Medicine and Hygiene 85:5, pages 820-825.
Crossref
Crossref
Supriya Khanra, Subir K. Bandopadhyay, Priyanka Chakraborty, Sanchita Datta, Dinesh Mondal, Mitali Chatterjee, Khudiram Naskar, Syamal Roy & Madhumita Manna. (2011) Characterization of the recent clinical isolates of Indian Kala-azar patients by RAPD-PCR method. Journal of Parasitic Diseases 35:2, pages 116-122.
Crossref
Crossref
L. Chitimia, C.I. Muñoz-García, D. Sánchez-Velasco, V. Lizana, L. del Río, L. Murcia, R. Fisa, C. Riera, P. Giménez-Font, P. Jiménez-Montalbán, Á. Martínez-Ramírez, J.M. Meseguer-Meseguer, I. García-Bacete, M.A. Sánchez-Isarria, G. Sanchis-Monsonís, J.D. García-Martínez, V. Vicente, M. Segovia & E. Berriatua. (2011) Cryptic Leishmaniosis by Leishmania infantum, a feature of canines only? A study of natural infection in wild rabbits, humans and dogs in southeastern Spain. Veterinary Parasitology 181:1, pages 12-16.
Crossref
Crossref
Grégory Michel, Christelle Pomares, Bernard Ferrua & Pierre Marty. (2011) Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. Acta Tropica 119:2-3, pages 69-75.
Crossref
Crossref
Florian AstelbauerAndreas ObwallerAdriane RaningerBrigitte BremHarald GregerMichael DuchêneWalther WernsdorferJulia Walochnik. (2011) Anti-Leishmanial Activity of Plant-Derived Acridones, Flavaglines, and Sulfur-Containing Amides. Vector-Borne and Zoonotic Diseases 11:7, pages 793-798.
Crossref
Crossref
Gláucia F. Cota, Marcos R. de Sousa & Ana Rabello. (2011) Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic Review. PLoS Neglected Tropical Diseases 5:6, pages e1153.
Crossref
Crossref
André Luis Souza dos Santos. (2011) Protease expression by microorganisms and its relevance to crucial physiological/pathological events. World Journal of Biological Chemistry 2:3, pages 48.
Crossref
Crossref
Carlos Andres Coy Barrera, Ericsson David Coy Barrera, Diana Susana Granados Falla, Gabriela Delgado Murcia & Luis Enrique Cuca Suarez. (2011) seco-Limonoids and Quinoline Alkaloids from Raputia heptaphylla and Their Antileishmanial Activity. Chemical and Pharmaceutical Bulletin 59:7, pages 855-859.
Crossref
Crossref
Erin Huiras Amerson & Toby A. Maurer. (2011) Immune Reconstitution Inflammatory Syndrome and Tropical Dermatoses. Dermatologic Clinics 29:1, pages 39-43.
Crossref
Crossref
Antonio Cascio, Maurizio Iaria & Chiara Iaria. (2010) Leishmaniasis and Biologic Therapies for Rheumatologic Diseases. Seminars in Arthritis and Rheumatism 40:3, pages e3-e5.
Crossref
Crossref
Elizabeth Valdivieso, Ariadne Rangel, Javier Moreno, Jose María Saugar, Carmen Cañavate, Jorge Alvar & Francehuli Dagger. (2010) Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp.. Experimental Parasitology 126:4, pages 557-563.
Crossref
Crossref
Oscar Cabezón, Javier Millán, Margalida Gomis, Jitender P. Dubey, Ezio Ferroglio & Sonia Almería. (2010) Kennel dogs as sentinels of Leishmania infantum, Toxoplasma gondii, and Neospora caninum in Majorca Island, Spain. Parasitology Research 107:6, pages 1505-1508.
Crossref
Crossref
J. L. N. Barratt, J. Harkness, D. Marriott, J. T. Ellis & D. Stark. (2010) Importance of Nonenteric Protozoan Infections in Immunocompromised People. Clinical Microbiology Reviews 23:4, pages 795-836.
Crossref
Crossref
Raquel Elisa da Silva-López, Tatiana Resende dos Santos, José Andrés Morgado-Díaz, Marcelo Neves Tanaka & Salvatore Giovanni de Simone. (2010) Serine protease activities in Leishmania (Leishmania) chagasi promastigotes. Parasitology Research 107:5, pages 1151-1162.
Crossref
Crossref
Vannan Kandi Vijayan & Tarek Kilani. (2010) Emerging and Established Parasitic Lung Infestations. Infectious Disease Clinics of North America 24:3, pages 579-602.
Crossref
Crossref
Ioannis Papanastasiou, Kyriakos C. Prousis, Kalliopi Georgikopoulou, Theofilos Pavlidis, Effie Scoulica, Nicolas Kolocouris & Theodora Calogeropoulou. (2010) Design and synthesis of new adamantyl-substituted antileishmanial ether phospholipids. Bioorganic & Medicinal Chemistry Letters 20:18, pages 5484-5487.
Crossref
Crossref
Essam Abdel‐Sattar, Louis Maes & Maha Mahmoud Salama. (2010)
In Vitro
activities of plant extracts from Saudi Arabia against malaria, leishmaniasis, sleeping sickness and Chagas disease
. Phytotherapy Research 24:9, pages 1322-1328.
Crossref
Crossref
Priscilla Alexandrino-de-Oliveira, Joanna Reis Santos-Oliveira, Maria Elizabeth Cavalheiros Dorval, Francisco das Chagas Brandão Da-Costa, Gracy Regina Oliveira Leite Pereira, Rivaldo Venâncio da Cunha, Anamaria Mello Miranda Paniago & Alda Maria Da-Cruz. (2010) HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil. Memórias do Instituto Oswaldo Cruz 105:5, pages 692-697.
Crossref
Crossref
Samuel C HumeCraig A AboltinsKarin A ThurskyJohn R DaffyPeter A Stanley. (2010) Visceral leishmaniasis due to Leishmania donovani in a patient with advanced HIV infection. Medical Journal of Australia 192:8, pages 474-475.
Crossref
Crossref
Pranav Kumar, Robert Lodge, Nathalie Trudel, Michel Ouellet, Marc Ouellette & Michel J. Tremblay. (2010) Nelfinavir, an HIV-1 Protease Inhibitor, Induces Oxidative Stress–Mediated, Caspase-Independent Apoptosis in Leishmania Amastigotes. PLoS Neglected Tropical Diseases 4:3, pages e642.
Crossref
Crossref
Pratistadevi K Ramdial. (2009) Dermatopathological challenges in the human immunodeficiency virus and acquired immunodeficiency syndrome era. Histopathology 56:1, pages 39-56.
Crossref
Crossref
ALAN J. MAGILL. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
3463
3480
.
Claudia Colomba, Laura Saporito, Fabrizio Vitale, Stefano Reale, Giustina Vitale, Alessandra Casuccio, Manlio Tolomeo, Daniela Maranto, Raffaella Rubino, Paola Di Carlo & Lucina Titone. (2009) Cryptic Leishmania infantum infection in Italian HIV infected patients. BMC Infectious Diseases 9:1.
Crossref
Crossref
Andrea Cristina Alpoim Botelho & Delsio Natal. (2009) Primeira descrição epidemiológica da leishmaniose visceral em Campo Grande, Estado de Mato Grosso do Sul. Revista da Sociedade Brasileira de Medicina Tropical 42:5, pages 503-508.
Crossref
Crossref
R. LÓPEZ, L. E. CUCA & G. DELGADO. (2009)
Antileishmanial and immunomodulatory activity of
Xylopia discreta
. Parasite Immunology 31:10, pages 623-630.
Crossref
Crossref
T. A. Patel & D. N. Lockwood. (2009) Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases. Tropical Medicine & International Health 14:9, pages 1064-1070.
Crossref
Crossref
Maysa F. Zampa, Inês M.S. Araújo, Vladimir Costa, Carlos H. Nery Costa, José Ribeiro SantosJr.Jr., Valtencir Zucolotto, Carla Eiras & José Roberto S.A. Leite. (2009) Leishmanicidal Activity and Immobilization of dermaseptin 01 antimicrobial peptides in ultrathin films for nanomedicine applications. Nanomedicine: Nanotechnology, Biology and Medicine 5:3, pages 352-358.
Crossref
Crossref
Donald A. Patrick, Stanislav A. Bakunov, Svetlana M. Bakunova, E.V.K. Suresh Kumar, Heidi Chen, Susan Kilgore Jones, Tanja Wenzler, Todd Barzcz, Karl A. Werbovetz, Reto Brun & Richard R. Tidwell. (2009) Synthesis and antiprotozoal activities of dicationic bis(phenoxymethyl)benzenes, bis(phenoxymethyl)naphthalenes, and bis(benzyloxy)naphthalenes. European Journal of Medicinal Chemistry 44:9, pages 3543-3551.
Crossref
Crossref
José Cerbino Neto, Guilherme Loureiro Werneck & Carlos Henrique Nery Costa. (2009) Factors associated with the incidence of urban visceral leishmaniasis: an ecological study in Teresina, Piauí State, Brazil. Cadernos de Saúde Pública 25:7, pages 1543-1551.
Crossref
Crossref
Jean-Pierre Dedet. 2009. Sequelae and Long-Term Consequences of Infectious Diseases. Sequelae and Long-Term Consequences of Infectious Diseases
275
289
.
Mohammad A. Oshaghi, Naseh Maleki Ravasan, Mallorie Hide, Ezat-Aldin Javadian, Yavar Rassi, Mohammad M. Sedaghat, Mehdi Mohebali & Homa Hajjaran. (2009) Development of species-specific PCR and PCR-restriction fragment length polymorphism assays for L. infantum/L. donovani discrimination. Experimental Parasitology 122:1, pages 61-65.
Crossref
Crossref
Svetlana M. Bakunova, Stanislav A. Bakunov, Donald A. Patrick, E. V. K. Suresh Kumar, Kwasi A. Ohemeng, Arlene S. Bridges, Tanja Wenzler, Todd Barszcz, Susan Kilgore Jones, Karl A. Werbovetz, Reto Brun & Richard R. Tidwell. (2009) Structure−Activity Study of Pentamidine Analogues as Antiprotozoal Agents. Journal of Medicinal Chemistry 52:7, pages 2016-2035.
Crossref
Crossref
Lívia O. Santos, Fernanda A. Marinho, Ellen F. Altoé, Bianca S. Vitório, Carlos R. Alves, Constança Britto, Maria Cristina M. Motta, Marta H. Branquinha, André L. S. Santos & Claudia M. d'Avila-Levy. (2009) HIV Aspartyl Peptidase Inhibitors Interfere with Cellular Proliferation, Ultrastructure and Macrophage Infection of Leishmania amazonensis. PLoS ONE 4:3, pages e4918.
Crossref
Crossref
Bhuwan B. Mishra, Raju R. Kale, Rakesh K. Singh & Vinod K. Tiwari. (2009) Alkaloids: Future prospective to combat leishmaniasis. Fitoterapia 80:2, pages 81-90.
Crossref
Crossref
Displaying 200 of 270 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list